Effects of lansoprazole: A Synthesis of Findings from 18 Studies
- Home
- Effects of lansoprazole
This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Effects of lansoprazole: A Synthesis of Findings from 18 Studies", please consult your doctor.
For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
Major Research Findings
Lansoprazole, a proton pump inhibitor, has been shown to effectively suppress gastric acid secretion in numerous studies. 5 found that lansoprazole is as effective as omeprazole in reducing gastric acidity in individuals with Helicobacter pylori infection. 2 demonstrated that lansoprazole can improve Helicobacter pylori infection and antral gastritis in duodenal ulcer patients. 3 investigated the efficacy of intravenous lansoprazole administration, concluding it to be effective in inhibiting gastric acid secretion. Lansoprazole has also been shown to be effective in healing duodenal ulcers, with 10 finding comparable healing rates to omeprazole. Moreover, 14 suggests that lansoprazole might be faster in alleviating gastroesophageal reflux symptoms than omeprazole. 16 highlights the importance of CYP2C19 genetic variation in determining lansoprazole’s pharmacokinetic profile.
Benefits and Risks
Benefit Summary
Lansoprazole has demonstrated effectiveness in treating various conditions related to excessive gastric acid production, including duodenal ulcers, gastric ulcers, and gastroesophageal reflux disease. 5 , 2 , 10 , 14 . Its efficacy in reducing gastric acidity and healing ulcers makes it a valuable option for managing these conditions.
Risk Summary
A potential risk associated with lansoprazole is an increase in serum gastrin levels, as observed in several studies like 12 . Additionally, some individuals may experience side effects such as skin rash and constipation as documented in 10 .
Comparison Across Studies
Commonalities Across Studies
A consistent finding across multiple studies is the effectiveness of lansoprazole in reducing gastric acid secretion. Numerous studies have demonstrated its efficacy in treating duodenal ulcers and other gastrointestinal conditions associated with excessive acid production.
Differences Across Studies
While several studies show lansoprazole to be comparable to omeprazole in its effectiveness, 14 suggests that lansoprazole may be faster in relieving gastroesophageal reflux symptoms. Furthermore, 16 indicates that CYP2C19 genetic variability can significantly affect lansoprazole’s pharmacokinetic profile.
Consistency and Contradictions in Results
The findings regarding lansoprazole’s effectiveness in managing gastric acidity and related conditions are generally consistent across various studies. However, there is some variability in its speed of action and the possibility of adverse effects like elevated gastrin levels. 12 , 14 . Further research is needed to better understand the factors influencing its therapeutic effects and potential risks in different individuals.
Points to Consider in Real-World Application
Lansoprazole can be a valuable treatment option for various gastrointestinal conditions, but it is crucial to use it as directed by a healthcare professional. 12 , 10 . It is essential to be aware of potential side effects and consult with your doctor if you experience any concerning symptoms. The use of lansoprazole should be personalized based on individual needs and medical history.
Limitations of Current Research
While considerable research has been conducted on lansoprazole, some aspects remain incompletely understood. For instance, the exact mechanism by which lansoprazole affects gastric lipase secretion and intragastric lipolysis requires further investigation. 15 . Additionally, the clinical significance of CYP2C19 genetic variability on lansoprazole’s pharmacokinetics requires more in-depth study. 16 . Furthermore, long-term effects of lansoprazole use warrant more extensive research to assess its safety and potential impact over extended periods.
Directions for Future Research
Future research should focus on better understanding the long-term effects of lansoprazole use, including its impact on gastrin levels and other potential consequences. 12 . Further investigation into the mechanism by which lansoprazole influences gastric lipase and intragastric lipolysis is also needed. 15 . Research is required to clarify the clinical significance of CYP2C19 genetic variability in determining lansoprazole’s effectiveness and potential adverse effects. 16 .
Conclusion
Lansoprazole has demonstrated effectiveness in suppressing gastric acid secretion and treating various gastrointestinal conditions like duodenal ulcers and gastroesophageal reflux disease. 5 , 2 , 10 , 14 . However, it is essential to use it as directed by a doctor and be aware of potential side effects. 12 , 10 . Further research is required to fully elucidate the long-term effects of lansoprazole and address other unanswered questions regarding its efficacy and safety.
Benefit Keywords
Risk Keywords
Article Type
Author: SandersS W, TolmanK G, GreskiP A, JenningsD E, HoyosP A, PageJ G
Language : English
Author: JhalaN C, McFarlandM M, BrightmanS A, MoraleB, RubinW, AtkinsonB F
Language : English
Author: InoueM, NakamuraM
Language : English
Author: YamamotoI, FukudaY, OkuiM, TamuraK, ShimoyamaT
Language : English
Author: VerdúE F, FraserR, ArmstrongD, BlumA L
Language : English
Author: Bruley des VarannesS, LevyP, LartigueS, DellatolasF, LemaireM, GalmicheJ P
Language : English
Author: PetiteJ P, SlamaJ L, LichtH, LemerezM, CosteT, AndrieuJ, GrimaudJ C, JulienH, DupuisJ, SallerinV
Language : French
Author: DammannH G, von zur MühlenA, BalksH J, DamaschkeA, SteinhoffJ, HennigU, SchwarzJ A, FuchsW
Language : English
Language : English
Comparison of lansoprazole and omeprazole in the short-term management of duodenal ulcers in Taiwan.
Author: ChangF Y, ChiangC Y, TamT N, NgW W, LeeS D
Language : English
Author: TolmanK G, SandersS W, BuchiK N, KarolM D, JenningsD E, RinghamG L
Language : English
Author: Arroyo VillarinoM T, Lanas ArbeloaA, Esteva DíazF, Ortego Fernández de RetanaJ, Sainz SamitierR
Language : English
Author: BlumR A, ShiH, KarolM D, Greski-RoseP A, HuntR H
Language : English
Author: JanczewskaI, SagarM, SjöstedtS, HammarlundB, IwarzonM, SeensaluR
Language : English
Author: RenouC, CarrièreF, VilleE, GrandvalP, Joubert-CollinM, LaugierR
Language : English
Author: IeiriI, KishimotoY, OkochiH, MomiyamaK, MoritaT, KitanoM, MorisawaT, FukushimaY, NakagawaK, HasegawaJ, OtsuboK, IshizakiT
Language : English
Author: KimJin Il, ParkSoo-Heon, KimJae Kwang, ChungIn Sik, ChungKyu Won, SunHee Sik
Language : English
Author: TolmanKeith G, TäubelJörg, WarringtonSteven, ChiuYi-Lin, PilmerBetsy L, PanWei-Jian
Language : English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.